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ABSTRACT 
 
pH-sensitive chemical exchange saturation transfer (CEST) MRI holds great promise for in vivo 
applications. However, CEST effect depends on not only exchange rate and hence pH, but also on the 
contrast agent concentration, which must be determined independently in order to quantify pH. 
Ratiometric CEST MRI normalizes the concentration effect by comparing CEST measurements of multiple 
labile protons from the same molecule to simplify pH determination. Iopamidol, a commonly used X-Ray 
contrast agent, has been explored as a ratiometric CEST agent for imaging pH. However, iopamidol CEST 
properties have not been solved, determination of which is important for optimization and quantification 
of iopamidol pH imaging. Our study applied Bloch-McConnell equations and numerically solved iopamidol 
multi-site pH-dependent chemical exchange properties. We found that iopamidol CEST MRI is suitable for 
measuring pH between 6 and 7.5 with an accuracy of 0.1 pH unit despite that T1 and T2 measurements 
varied substantially with pH and concentration. Moreover, we determined base-catalyzed chemical 
exchange for both 2-hydrooxypropanamido (ksw=1.2*10 
pH-4.1) and amide (ksw=1.2*10 
pH-4.6) proton groups 
that are statistically different from each other (P<0.01, ANCOVA), understanding of which should help 
guide optimization and translation of iopamidol pH imaging under various experimental conditions. 
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1. INTRODUCTION 
 
Chemical exchange saturation transfer (CEST) MRI is sensitive to microenvironment properties 
including pH, temperature, metabolites, metal ions, and enzyme activities, and has been increasingly 
applied in vivo (Ward et al., 2000; Aime et al., 2002; Zhang et al., 2005; Sun and Sorensen, 2008; Woods 
et al., 2006; van Zijl and Yadav, 2011; Olatunde et al., 2012; Dula et al., 2012; Hingorani et al., 2013; 
Vinogradov et al., 2013; Castelli et al., 2013). Particularly, CEST MRI is sensitive to pH, an informative 
biomarker for metabolic disruption in disorders such as acute ischemic stroke and renal injury (Jokivarsi 
et al., 2007; Sun et al., 2007b; Sun et al., 2011a; Chan et al., 2013; Jin et al., 2012; Sun et al., 2012). 
However, CEST MRI contrast varies not only with exchange rate, and hence pH, but also with the CEST 
agent concentration, bulk water relaxation rates and experimental conditions (Sun et al., 2005; Terreno 
et al., 2010; Wu et al., 2012; Sun, 2012; Zaiss and Bachert, 2013; Sun et al., 2014a). Because the labile 
proton concentration has to be independently determined in order to derive pH, the conventional CEST 
imaging only provides pH-weighted information (Sun, 2010b; Zu et al., 2012; Sun et al., 2013b). To 
address this limitation, ratiometric CEST MRI has been proposed that normalizes the confounding 
concentration effect for simplifying pH measurement (Ward and Balaban, 2000; Ali et al., 2009; Liu et al., 
2012). A particularly interesting ratiometric MRI agent is iopamidol, approved by food and drug 
administration (FDA) as a X-Ray contrast agent since 1980s, which has been recently shown capable of 
imaging renal pH (Longo et al., 2012; Longo et al., 2011; Aime et al., 2005).  
 
Because of the tremendous interest in investigating iodinated agents for pH imaging, it is 
important to quantify their CEST properties, which should shed light on their sensitivity and detectability. 
Briefly, we used the Bloch–McConnell equations to describe multi-site iopamidol CEST effects (Woessner 
et al., 2005; McMahon et al., 2006; Sun et al., 2007a; Li et al., 2008; Murase and Tanki, 2011; Sun, 
2010a). We numerically derived multi-site labile proton ratio and exchange rate, and found that chemical 
exchange for both 2-hydrooxypropanamido and amide protons are dominantly base-catalyzed for the 
range of pH we investigated. We also determined the accuracy of iopamidol pH imaging is 0.1 pH unit 
despite that T1 and T2 measurements varied substantially with pH and concentration. Because 
   
understanding of iopamidol exchange properties is necessary for optimizing the pulsed-RF irradiation in 
clinic, our study should aid clinical translation of iopamidol pH imaging (Sun et al., 2008; Sun et al., 
2011b; Schmitt et al., 2011; Sun et al., 2013a; Zhu et al., 2010; Zu et al., 2011). 
 
2. MATERIALS AND METHODS 
Phantom 
We prepared 20 and 40 mM iopamidol (Bracco Imaging, S.p.A., Milan, Italy) phosphate buffered 
solution with pH titrated to 5.5, 6, 6.5, 7, 7.5 and 8 (EuTech pH Meter, Singapore). The solution was 
transferred into micro-centrifuge tubes and then inserted into two separate phantom containers. The 
phantom containers were filled with low gelling point agarose solution and solidified under room 
temperature.  
 
MRI and Data Processing 
 Experiments were obtained using a 4.7 Tesla MRI scanner (Bruker Biospec, Billerica, MA) at room 
temperature. Image readout was single-shot echo planner imaging (EPI) with a field of view of 48x48 mm, 
image matrix =64x64 and slice thickness =3 mm. T1 was measured using inversion recovery MRI, with 
seven inversion times (TI) ranging from 100 to 7,500 ms. We chose a long recovery time between image 
readout and the next inversion pulse to be 12,000 ms so that steady state could be obtained. The echo 
time (TE) was 39.5 ms and number of average (NSA) was 2. For T2 MRI, we used SE EPI with six TE from 50 
to 1,000 ms (TR=12,000 ms, NSA =2). For CEST MRI, we obtained Z-spectra ranging from -7 to 7 ppm, at 
intervals of 0.25 ppm (i.e., ±1400 Hz per 50 Hz at 4.7T). Continuous wave (CW) RF saturation was applied 
for 5 s (TS), with its amplitude varied from 1, 1.5, 2, 2.5, 3 to 4 μT (TR/TE =12,000/39.5 ms, NSA =2).  
 
Data were processed in MATLAB (MathWorks, Natick, MA). T1 and T2 were obtained by least 
squares fitting of the image intensity as a function of inversion time and echo time, respectively. We fit 
asymmetry plots using modified Bloch–McConnell equations (Sun, 2010a). CEST effect was calculated using 
CEST ratio (CESTR) 







=          (1) 
where Iref and Ilabel are the reference and label scans, and I0 is the control scan (i.e., B1 = 0). pH sensitive 
ratiometric CEST effect was calculated using relative CESTR and inverse relative saturation transfer 
(RSTinv), as defined by Longo et al (Longo et al., 2011). Specifically, we have 
































=η . In addition, the contrast to noise ratio (CNR) between pH 6 and 













=        (4) 
where CESTR and σ represent the mean CESTR and its standard deviation for each pH compartment. For 
the numerical fitting, we fixed the relative labile proton ratio for 5.5 (2-hydrooxypropanamido group), 4.3 
(amide group), 1.8 (secondary hydroxyl group) and 0.8 (primary hydroxyl groups) ppm be 1:2:1:4. Eleven 
parameters were determined from the numerical fitting, including T1w, T2w, 2-hydrooxypropanamido labile 
proton ratio, and labile proton exchange rate and T2s for each labile proton at 5.5, 4.3, 1.8 and 0.8 ppm. 
We used least squares optimization to minimize the error function, given 






expfit δCSETRδCSETRε . The fitting was repeated for each pH and RF power level. Results 








Fig. 1 compares simulated Z-spectra and asymmetry plots of two exchangeable sites at 4.3 and 5.5 
ppm with their labile proton ratio with respect to bulk water being 1:1500 and 1:3000 at exchange rates 
of 50 and 200 s-1, respectively (B1 =2.5 μT, TS =5 s). We chose representative relaxation rates of T1w =3 s, 
T1s =1 s, T2s =0.5 s, and varied T2w from 1 to 2 s. CEST effects could be observed at 4.3 and 5.5 ppm (Fig. 
1a). Z-spectral signal close to the bulk water resonance strongly depends on T2w due to direct RF 
saturation. Because the asymmetry analysis subtracts the symmetric direct RF saturation effect, it is 
substantially less susceptible to T2w variation. We measured the change in Z-spectra and asymmetry plots 










 − ) is significantly higher in Z-spectrum than asymmetry plot (2.85±3.06 
vs. 0.01±0.01, P<0.01). Because the asymmetry plot is less susceptible to moderate T2w difference than Z-
spectra, we chose to solve iopamidol CEST properties by fitting the asymmetry plots. 
 
Fig. 2 evaluates pH-sensitive iopamidol CEST imaging. Fig. 2a shows three representative Z-
spectra at pH of 6, 7 and 8 (B1 =2.5 μT). It is important to note that CEST effects from amide (4.3 ppm) 
and 2-hydrooxypropanamido (5.5 ppm) could be reasonably resolved for pH 6 and 7, they however, 
merged into one broad peak at pH of 8. Fig. 2b shows CEST asymmetry ratio (CESTR) calculated at 4.3 
(circles) and 5.5 ppm (squares). While CEST effect initially increased with pH, CESTR at 5.5 ppm peaked 
at pH of 7 and CESTR at 4.3 ppm peaked at pH of 7.5 (Fig. 2b). The unequal pH dependence of CESTR at 
4.3 and 5.5 ppm enables ratiometric pH quantification. Fig. 2c shows that the rCESTR increases from 0.6 ± 
0.1 to 2.3 ± 0.1 for pH at 6 and 7.5, respectively. We also measured T1 and T2. T1 decreased substantially 
with concentration (P<0.01, 2-sample t-test) but showed little pH dependence (P>0.15, linear regression). 
T1w was 2.68 ± 0.01s and 2.51 ± 0.01 s for 20 and 40 mM iopamidol solutions, respectively. In contrast, T2 
decreased substantially with pH (P<0.01, linear regression) and concentration (P<0.01, paired t-test). For 
20 mM iopamidol solution, T2w (pH)=2.46-0.23*pH (s), whereas for 40 mM, T2w (pH)=1.93-0.20*pH (s).  
 
   
We investigated the optimal RF irradiation level for ratiometric pH imaging. Fig. 3 a shows 
measured CESTR at 4.3 (circles) and 5.5 ppm (squares) for pH of 6 and 7.5 (B1=2.5 μT). CESTR increased 
with RF irradiation level, suggesting that a relatively high B1 irradiation field is needed to efficiently 
saturate iopamidol labile groups. Whereas CESTR at 5.5 ppm was higher than that at 4.3 ppm for pH of 6, 
the relative magnitude of CEST effect at 5.5 and 4.3 ppm reversed at pH of 7.5. We quantified 
ratiometric pH MRI using two indices: rCESTR and RSTinv, as defined by Longo et al (Longo et al., 2011). 
The contrast to noise ratio (CNR) between pH 6 and 7.5 compartments initially increased with B1 and 
peaked at an intermediate B1 of 2.5 μT (Fig. 3b). This shows that whereas the magnitude of pH contrast 
measured by ΔRSTinv is statistically higher than that of ΔrCESTR (P<0.01, ANCOVA), there was relatively 
small difference in CNR up to the optimal B1 saturation field. Fig. 3c shows the ratiometric CESTR map, 
demonstrating good pH contrast between 6 and 7.5.  
 
We determined the accuracy of iopamidol pH mapping. Fig. 4a shows that the logarithmic rCESTR 
can be described by polynomial regression (log10(rCESTR)=0.13*pH
2-1.34*pH+3.26) for 40 mM iopamidol 
solution, with R2=0.998 (P<0.01). The polynomial regression enables derivation of absolute pH map from 
pH-weighted rCESTR image for 40 mM (Fig. 4b) and 20 mM iopamidol (Fig. 4c). For 40 mM iopamidol, we 
found being 5.99±0.23, 6.46±0.06, 7.03±0.02 and 7.49±0.02 for pH of 6.0, 6.5, 7.0 and 7.5, respectively. 
pH determined from MRI strongly correlates with calibrated pH, pH(MRI)=1.01*pH-0.10 (P<0.01). 
Moreover, the intercept is not significant different from zero, suggesting no systematic biases in pH 
determination. For 20 mM iopamidol, we found being 6.01±0.36, 6.46±0.20, 7.09±0.08 and 7.55±0.08 for 
pH of 6.0, 6.5, 7.0 and 7.5, respectively. We found pixel-wise determined pH for 20 mM iopamidol is 
pH(MRI)=1.03*pH-0.15 (P<0.01). The intercept is not statistically significant different from zero (Fig. 4d).  
Our data showed that the standard deviation was higher at lower pH and iopamidol concentration, 
suggesting that it is governed by signal to noise ratio (SNR) of CEST MRI measurement. This is because 
exchange rate is reduced at lower pH, hence the CEST effect and SNR decreases with pH and iopamidol 
concentration. Because sensitivity can be improved with signal averaging, use of sensitive hardware and 
novel pulse sequence designs (Sun et al., 2014b), the pH accuracy for the ratiometric iopamidol MRI 
approach can be reasonably determined using the maximal difference between the measurement mean 
   
and the theoretical value, within ±0.1. Both χ2 and R2 tests showed good fitting. We found χ2 was less 
than 10-3 for pH measurement from both iopamidol solutions, substantially smaller than χ20.05 (i.e., 7.82) 
for three degrees of freedom. In addition, R2 was higher than 0.99 for pH measurement from both 
iopamidol solutions. Furthermore, ANCOVA analysis of pH measurements from 20 and 40 mM iopamidol 
phantoms showed no significant effect of iopamidol concentration on pH calibration, confirming that 
iopamidol ratiometric pH imaging can indeed measure pH despite a substantial difference in iopamidol 
concentration.   
 
We numerically solved iopamidol CEST properties using the Bloch-McConnell equations. Because 
CEST peaks could not be resolved at pH of 8 due to very fast chemical exchange, we numerically fit CEST 
asymmetry plots for pH from 5.5 to 7.5 under B1 irradiation level of 1, 1.5, 2, 2.5, 3 and 4 μT. Due to non-
negligible CEST effects from hydroxyl groups, a five-pool exchange model was chosen to describe 
iopamidol CEST measurements, including 2-hydrooxypropanamido protons (5.5 ppm), amide (4.3 ppm), 
two chemically not-equivalent hydroxyl groups (1.8 and 0.8 ppm) and bulk water (set to be 0 ppm). In 
addition, we set labile proton T1 (T1s) to be 1 s due to the use of long RF irradiation. B0 inhomogeneity 
was determined to be 5±6 Hz. Nevertheless, to reduce field inhomogeneity effect very close to bulk water 
signal, we fit CEST asymmetry from 0.75 to 7 ppm. The numerical fitting and experimental data under the 
optimal RF power level of 2.5 µT were shown in Fig. 5a. The coefficient of determination (R2) for all pH 
values was 0.99 ±0.01, and the squared residuals error between numerical fitting and experimental 
measurements was 0.30±0.77%. The fitting took approximately 4 min for each RF power level. Fig. 5b 
shows that the exchange rate at 4.3 and 5.5 ppm can be reasonably described using a dominantly base-
catalyzed exchange equation (i.e., ksw=k0+kb·10
pH-pkw). We found ksw(5.5 ppm)=1.2·10
pH-4.1 for 2-
hydrooxypropanamido protons and ksw(4.3 ppm)=1.2·10
pH-4.6 for amide protons (Table 1). Statistical test of 
logarithmic exchange rate confirmed significant difference in their exchange rate (P<0.01, ANCOVA). In 
addition, the 2-hydrooxypropanamido labile proton ratio with respect to bulk water can be estimated to 
be 1:2778, while that solved from numerical fitting was 1:3449 ± 747, not significantly different from the 
theoretical estimation (P>0.05, one sample t-test). Moreover, numerical fitting determined T1w=3.5±0.3 s, 
T2w=1.6±0.1 s, and T2s was 0.6±0.3, 1.5±0.4, 0.7±0.4 and 0.8±0.2 s for 2-hydrooxypropanamido protons 
   
(5.5 ppm), amide (4.3 ppm), and two hydroxyl groups at (1.8 and 0.8 ppm), respectively. Understanding 
pH-dependent exchange properties should help guide experimental optimization and quantification of 
iopamidol pH imaging under various experimental conditions such as pulsed RF irradiation scheme at 





Our study quantitatively solved the multi-site exchange properties of iopamidol. We confirmed 
that iopamidol ratiometric CEST MRI is capable of measuring pH from 6 to 7.5 at 4.7 T with an accuracy of 
0.1 pH unit despite that T1 and T2 measurements varied substantially with pH and concentration. 
Iopamidol pH imaging is promising to complement pH measurement techniques including pH-weighted 
CEST MRI, 31P MR spectroscopy (MRS), and dual modality (positron emission tomography (PET)-MRI) 
contrast-enhanced imaging (Adam et al., 1986; Frullano et al., ; Sheth et al., 2012). Clinical iopamidol 
dosage is procedure specific. For example, the recommended dosage is 40-150 ml of Isovue 300-370 for 
whole body computer tomography enhancement (Iopamidol Product Monograph). In this case, the 
iopamidol concentration in blood can be estimated to be about 6-29 mM. Iopamidol concentration is also 
organ specific, likely being more concentrated in kidney and bladder. Indeed, Longo et al. have 
successfully imaged acute renal injury-induced pH change using iopamidol ratiometric CEST MRI (Longo et 
al., 2012). Accurate pH imaging can complement a number of MRI applications (Kogan et al., 2014; 
Dagher et al., 2000). For example, Dagher et al. showed that urea, an important kidney metabolite, can 
be imaged using CEST MRI (Dagher et al., 2000). Because urea hydroxyl chemical exchange is pH-
dependent, pH has to be measured independently in order to derive urea concentration, for which 
iopamidol pH MRI is applicable.  
 
Because high magnetic field provides enhanced sensitivity for diamagnetic CEST (DIACEST) MRI, 
iodinated contrast agent-based pH imaging has been initially demonstrated at 7 Tesla (Chen et al., 2013; 
Longo et al., 2012). In addition to more efficient spin polarization, T1 also increases at high field strength, 
   
leading to stronger CEST effect. Moreover, because the frequency shift in Hz scales linearly with field 
strength, the concomitant direct RF saturation is reduced at high field. We here demonstrated iopamidol 
pH imaging at 4.7 Tesla, substantiating its translation potential. We also compared two means of pH 
calculation: rCESTR and RSTinv. Whereas ΔRSTinv is statistically larger than ΔrCESTR between pH 6 and 7.5, 
there was relatively small difference in their CNR due to error propagation from the correction factor 
(Fig. 3). It is important to note that because our ability to resolve pH difference relies upon CNR, both 
rCESTR and RSTinv provide similar pH sensitivity. Our study showed that pH can be accurately determined 
despite substantial pH and iopamidol concentration-induced T1 and T2 change. Also, worth noting is that 
iopamidol labile proton groups are reasonably close to endogenous amide protons and semisolid 
macromolecules, which may have to be considered in order to quantify in vivo ratiometric pH imaging 
(Henkelman et al., 1994; Zhou et al., 2004; Jones et al., 2013; Scheidegger et al., 2011). It has been 
shown by Chen et al. that Lorentzian line shape fitting could overcome the NOE and MT contributions and 
enable extracellular pH determination within in vivo tumors (Chen et al., 2013).  
 
It is necessary to note that it is technically challenging to determine exchange properties in a 
multi-site CEST system. T2-based solution could not resolve multi-site exchange (Aime et al., 2005). 
Although the Lorentzian spectral analysis is capable of estimating exchange rate, it is difficult to solve 
multi-site exchange that are close to each other (Allerhand et al., 1966). Our work addressed an 
important aspect of quantitative CEST analysis. We showed that the modified Bloch-McConnell equations 
can reasonably describe multi-site CEST phenomenon, with small residual errors between the fitting and 
experimental measurement. The numerically solved labile proton ratio is in reasonable agreement with 
estimation, and the exchange rate can be well described by a base-catalyzed chemical exchange 
relationship. While it is necessary to include hydroxyl groups in order to fit the asymmetry plots at 4.3 
and 5.5 ppm, hydroxyl chemical exchange rates are in the fast exchange regime. Therefore, the 
numerically derived exchange rates for hydroxyl groups may be subject to non-negligible fitting errors but 
provide good estimates of their order of magnitude. It is important to note that understanding pH-
dependent exchange properties could help guide experimental optimization and quantification of 
iopamidol pH imaging. Briefly, because continuous wave (CW) RF irradiation scheme is not routinely 
   
available on clinical scanners, pulsed RF irradiation has to be chosen. The irradiation pulse duration, flip 
angle and inter-pulse delay of CEST MRI have to be optimized based on chemical exchange rate and pulse 
sequence (Sun et al., 2008; Sun et al., 2011b; Schmitt et al., 2011; Sun et al., 2013a; Zhu et al., 2010; 
Sun et al., 2014b). Therefore, determination of pH-dependent exchange rate should aid clinical 





Our study numerically derived multi-site iopamidol exchange properties and showed that chemical 
exchange rates for 2-hydrooxypropanamido and amide groups were dominantly base-catalyzed and 
statistically different from each other, making iopamidol a sensitive ratiometric pH MRI agent. We further 
showed that the sensitivity of iopamidol pH imaging peaked at an intermediate RF irradiation level, and 
iopamidol CEST MRI is suitable for measuring pH between 6 and 7.5 with an accuracy of 0.1 pH unit 
despite that T1 and T2 measurements varied substantially with pH and concentration. Our study remains 
promising to help optimize and translate iopamidol pH imaging to the clinic. 







ksw (5.5 ppm) 
 
ksw (4.3 ppm) 
 
ksw (1.8 ppm) 
 
ksw (0.8 ppm) 
5.5 47 ± 12 s-1 7 ± 4 s-1 388 ± 157 s-1 2070 ± 331 s-1 
6 87 ± 34 s-1 17 ± 6 s-1 242 ± 188 s-1 1759 ± 519 s-1 
6.5 265 ± 65 s-1 67 ± 15 s-1 416 ± 166 s-1 1856 ± 1567 s-1 
7 1074 ± 298 s-1 190 ± 25 s-1 1104 ± 337 s-1 1715 ± 483 s-1 
7.5 2896 ± 285 s-1 868 ± 260 s-1 9262 ± 6138 s-1 5117 ± 4485 s-1 
 
Table 1, Numerically determined pH-dependent exchange rates for labile protons at 5.5 (2-
hydrooxypropanamido group), 4.3 (amide group), 1.8 (secondary hydroxyl group) and 0.8 (primary 
hydroxyl groups) ppm. Data are shown in mean ± standard deviation. The relative labile proton ratio 
for 5.5, 4.3, 1.8 and 0.8 ppm was fixed to be 1:2:1:4, with labile proton ratio at 5.5 ppm determined 
to be 1:3449 ± 747. 
 
 







Fig. 1, a) Simulated CEST Z-spectra and asymmetry-plots for three representative bulk water T2w  of 0.5, 1 
and 1.5 s. (B1 =2.5 μT). b) Two plots of sum of squares analysis of the difference in simulated CEST Z-
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Fig. 2, Iopamidol ratiometric pH MRI. a) Z-spectra for representative pH of 6, 7 and 8 (B1 =2.5 µT, TS =5s) 
at room temperature. b) CEST ratio (CESTR) calculated from the asymmetry analysis as a function of pH. 
CESTR at 4.3 ppm peaks at pH 7.5 while CESTR of 5.5 ppm peaks at pH 7. c) Ratiometric CEST analysis is 











Fig. 3, B1-dependence of iopamidol ratiometric pH MRI. a) CESTR at 4.3 and 5.5 ppm increases with B1 
irradiation level for representative pH of 6 and 7.5. b) CNR in ratiometric pH MRI between pH of 6 and 7.5 
peaks under an intermediate optimal B1 level of 2.5 μT. c) pH-weighted rCESTR map (B1 =2.5 μT). 
 







Fig. 4, Evaluation of the accuracy of iopamidol pH imaging. a) Logarithmic rCESTR as a function of pH for 
40 mM iopamidol. b) pH map determined from pH-weighted rCESTR map for 40 mM iopamidol. c) pH map 
determined from pH-weighted rCESTR map for 20 mM iopamidol. d) pH determined from iopamidol pH MRI 
vs. titrated pH for 20 mM (circles) and 40 mM (squares) iopamidol phantoms. 










Fig. 5, Numerical solution of iopamidol pH-dependent chemical exchange properties. a) Numerical fitting 
of asymmetry plots (B1 =2.5 μT). b) Numerically determined pH-dependent chemical exchange for labile 
protons at 4.3 and 5.5 ppm. 
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